Compound class:
Synthetic organic
Comment: YCT529 is an oral retinoic acid receptor alpha (RAR-α) antagonist, that is being investigated as a non-hormonal male contraceptive. Its development and function were presented at the spring meeting of the American Chemical Society (ACS) in March 2022. Antagonising RAR-α disrupts spermatogenesis. YCT529 is formulated as a sodium salt. The RAR-α-selective antagonists BMS-189532 and BMS-189614 have been reported previously [1-2].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Database Links ![]() |
|
GtoPdb PubChem SID | 461663509 |
Search Google for chemical match using the InChIKey | QLXSCDXZOYRDAX-UHFFFAOYSA-M |
Search Google for chemicals with the same backbone | QLXSCDXZOYRDAX |
UniChem Compound Search for chemical match using the InChIKey | QLXSCDXZOYRDAX-UHFFFAOYSA-M |
UniChem Connectivity Search for chemical match using the InChIKey | QLXSCDXZOYRDAX-UHFFFAOYSA-M |